IDRI Partners with Global Research Initiative ADITEC to Accelerate Human Vaccine Development

October 17th, 2011|Press Releases|

Seattle, WA | October 17, 2011 The Infectious Disease Research Institute (IDRI) has joined the Advanced Immunization Technologies (ADITEC) program, a collaborative initiative dedicated to accelerating the development of the next generation of human vaccines. Launched on October 1st, [...]

The Paul G. Allen Family Foundation Supports Launch of IDRI’s TB Vaccine Clinical Program

October 12th, 2011|Press Releases|

Seattle, WA | October 12, 2011 The Infectious Disease Research Institute (IDRI) has been awarded a two-year $300,000 grant from The Paul G. Allen Family Foundation to support IDRI's launch of a Phase 1 clinical trial of its new [...]

GlaxoSmithKline Donates Scientific Equipment to Advance IDRI’s Global Health Mission

October 3rd, 2011|Press Releases|

Seattle, WA | October 3, 2011 The Infectious Disease Research Institute (IDRI) announces today that GlaxoSmithKline (GSK) Biologicals Hamilton has donated a broad range of instrumentation and equipment that will assist IDRI as it designs and validates solutions to [...]

IDRI Launches New and Improved Website

September 7th, 2011|Press Releases|

Seattle, WA | September 7, 2011 The Infectious Disease Research Institute (IDRI) announced today the launch of its new and improved website,www.idri.org. IDRI's website now boasts a revitalized design, streamlined navigation, and expanded information about its product pipeline, with [...]

IDRI, USAID Strike New Collaboration for Malaria Vaccine Development

August 16th, 2011|Press Releases|

Seattle, WA | August 16, 2011 The Infectious Disease Research Institute (IDRI) today announced a new Memorandum of Understanding with the United States Agency for International Development (USAID), focused on support of a collaboration with the Walter Reed Army [...]

IDRI Announces New EVP Business Development & External Affairs

August 2nd, 2011|Press Releases|

Seattle, WA | August 2, 2011 The Infectious Disease Research Institute (IDRI) announced today that Erik Iverson, Associate General Counsel for Global Health at the Bill & Melinda Gates Foundation, will join IDRI in September as its EVP Business [...]

IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer

February 15th, 2011|Press Releases|

Seattle, WA | February 15, 2011 The Infectious Disease Research Institute (IDRI) announces today the appointment of H. Stewart Parker as its new Chief Executive Officer and new member of the IDRI board of directors. Parker is a widely [...]

IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs

January 14th, 2011|Press Releases|

Seattle, WA | January 14, 2011 The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in [...]

IDRI Receives DARPA Grant to Develop a Novel Vaccine to Combat Pandemic Flu

January 7th, 2011|Press Releases|

Seattle, WA | January 7, 2011 The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency (DARPA), and the Army Research Office (ARO), both parts of United [...]

IDRI Awarded $790,200 Grant from US Government to Develop Pandemic Flu Vaccine With Cantacuzino Institute

December 3rd, 2010|Press Releases|

Seattle, WA | December 3, 2010 The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. [...]

Load More